GU Cancers 2023 | Key unmet needs in kidney cancer

Thomas Powles, MBBS, MRCP, MD, Barts Cancer Institute, London, UK, discusses key unmet needs in kidney cancer, including the need for biomarkers for personalized treatment decision making, particularly circulating biomarkers, and more trials in the perioperative space. This interview took place at the ASCO GU Cancers Symposium 2023 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.